{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:03:57Z","timestamp":1784347437988,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.msard.2025.106792","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:57:23Z","timestamp":1760223443000},"page":"106792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Characterizing post-COVID-19 syndrome in multiple sclerosis: Vaccine status, infection burden, and therapy categories as predictors"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9042-0189","authenticated-orcid":false,"given":"Deepak","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3906-0161","authenticated-orcid":false,"given":"Christian P.","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-7021","authenticated-orcid":false,"given":"Robert","family":"Hoepner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6746-1034","authenticated-orcid":false,"given":"Iris-Katharina","family":"Penner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2504-8935","authenticated-orcid":false,"given":"Thomas","family":"Nyffeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-5761","authenticated-orcid":false,"given":"Lara","family":"Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.msard.2025.106792_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119231","article-title":"COVID-19: the course, vaccination and Immune response in people with Multiple sclerosis: systematic review","volume":"24","author":"Bazylewicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.msard.2025.106792_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/diseases12050095","article-title":"Long COVID in children, adults, and vulnerable populations: a comprehensive overview for an integrated approach","volume":"12","author":"Calcaterra","year":"2024","journal-title":"Diseases."},{"issue":"1","key":"10.1016\/j.msard.2025.106792_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27797-1","article-title":"Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome","volume":"13","author":"Cervia","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.msard.2025.106792_bib0004","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","article-title":"Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review","volume":"226","author":"Chen","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.msard.2025.106792_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000991","article-title":"Vaccine hesitancy in patients with multiple sclerosis","volume":"8","author":"Diem","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"32","key":"10.1016\/j.msard.2025.106792_bib0006","doi-asserted-by":"crossref","first-page":"866","DOI":"10.15585\/mmwr.mm7232a3","article-title":"Long COVID and significant activity limitation among adults, by age \u2014 United States, June 1\u201313, 2022, to June 7\u201319, 2023","volume":"72","author":"Ford","year":"2023","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"issue":"6","key":"10.1016\/j.msard.2025.106792_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.19766","article-title":"Association between Anti-CD20 therapies and COVID-19 severity among patients with relapsing-remitting and progressive multiple sclerosis","volume":"6","author":"Januel","year":"2023","journal-title":"JAMa Netw. Open."},{"issue":"3\u20134","key":"10.1016\/j.msard.2025.106792_bib0008","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000360528","article-title":"Multiple Sclerosis: current knowledge and future outlook","volume":"72","author":"Kamm","year":"2014","journal-title":"Eur. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106792_bib0009","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3988\/jcn.2022.0348","article-title":"Outcome of COVID-19 infection in patients with multiple sclerosis who received disease-modifying therapies: a systematic review and meta-analysis","volume":"19","author":"Liu","year":"2023","journal-title":"J. Clin. Neurol."},{"issue":"163","key":"10.1016\/j.msard.2025.106792_bib0010","first-page":"31","article-title":"Post-acute COVID-19 syndrome","author":"Montani","year":"2022","journal-title":"Eur. Respirat. Rev."},{"key":"10.1016\/j.msard.2025.106792_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.580507","article-title":"The psychological impact of COVID-19 Pandemic on people with multiple sclerosis","volume":"11","author":"Motolese","year":"2020","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106792_bib0012","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"key":"#cr-split#-10.1016\/j.msard.2025.106792_bib0013.1","unstructured":"Official data collated by Our World in Data (2024)"},{"key":"#cr-split#-10.1016\/j.msard.2025.106792_bib0013.2","unstructured":"World Health Organisation (2025)"},{"key":"#cr-split#-10.1016\/j.msard.2025.106792_bib0013.3","unstructured":"population based on various sources (2024) - with major processing by our World in Data. (n.d.). Retrieved May 5, 2025, from https:\/\/ourworldindata.org\/coronavirus."},{"issue":"3","key":"10.1016\/j.msard.2025.106792_bib0014","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/jcm14030952","article-title":"Differential fatigue profile in patients with post-COVID condition, fibromyalgia, and Multiple sclerosis","volume":"14","author":"Oliver-Mas","year":"2025","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.msard.2025.106792_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/NNR.0000000000000565","article-title":"Post-COVID-19 syndrome","volume":"71","author":"Pierce","year":"2022","journal-title":"Nurs. Res."},{"key":"10.1016\/j.msard.2025.106792_bib0016","unstructured":"Post COVID-19 condition (Long COVID). (n.d.). Retrieved June 7, 2024, from https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition."},{"key":"10.1016\/j.msard.2025.106792_bib0017","first-page":"44","article-title":"COVID-19 and multiple sclerosis: challenges and lessons for patient care","author":"Prosperini","year":"2024","journal-title":"Lancet Regional Health. Europe"},{"issue":"1","key":"10.1016\/j.msard.2025.106792_bib0018","doi-asserted-by":"crossref","DOI":"10.1186\/s42466-021-00143-y","article-title":"Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany","volume":"3","author":"Richter","year":"2021","journal-title":"Neurol. Res. Pract."},{"key":"10.1016\/j.msard.2025.106792_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1186404","article-title":"The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and our World in Data","volume":"14","author":"Salmen","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4\u20135","key":"10.1016\/j.msard.2025.106792_bib0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/13524585221150881","article-title":"Safety of COVID-19 vaccines in multiple sclerosis: a systematic review and meta-analysis","volume":"29","author":"Stefanou","year":"2023","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2025.106792_bib0021","first-page":"183","article-title":"Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis","author":"Tsampasian","year":"2023","journal-title":"JAMa Intern. Med."},{"issue":"5","key":"10.1016\/j.msard.2025.106792_bib0022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s15005-022-2307-3","article-title":"Aktuelle leitliniengerechte therapie der multiplen Sklerose","volume":"24","author":"Wenzel","year":"2022","journal-title":"InFo Neurologie + Psychiatrie"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:27:24Z","timestamp":1784345244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":24,"alternative-id":["S2211034825005346"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106792","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing post-COVID-19 syndrome in multiple sclerosis: Vaccine status, infection burden, and therapy categories as predictors","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106792"}}